Literature DB >> 15727235

Devic's neuromyelitis optica: clinical features and prognostic factors.

R Bergamaschi1, A Ghezzi.   

Abstract

Devic's neuromyelitis optica (NMO) onset is characterized by optic neuritis (ON) and transverse myelitis (TM), either simultaneously or in isolation. Thereafter, the course of the disease can be monophasic (no other attack) or relapsing (sequences of ON and TM, no other neurological system involved). The risk of having a relapsing course is related to gender, older age at onset, less severe motor impairment after the myelitic onset, interval length between first and second attack. The risk of an unfavourable evolution (severe disability or death) during a relapsing course is mainly related to high relapse rate during the first two years of the disease. In summary, relapsing NMO patients tend to have a poor prognosis, requiring more effective immunosuppressive treatments.

Entities:  

Mesh:

Year:  2004        PMID: 15727235     DOI: 10.1007/s10072-004-0342-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

Review 1.  Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature.

Authors:  Paira Sergio; Benegas Mariana; Ortiz Alberto; Uña Claudia; Rillo Oscar; Mannucci Pablo; Allievi Alberto
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

Review 2.  Acquired pathology of the pediatric spine and spinal cord.

Authors:  Susan Palasis; Laura L Hayes
Journal:  Pediatr Radiol       Date:  2015-09-07

3.  Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

Authors:  I Nakashima; K Fujihara; I Miyazawa; T Misu; K Narikawa; M Nakamura; S Watanabe; T Takahashi; S Nishiyama; Y Shiga; S Sato; B G Weinshenker; Y Itoyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02-27       Impact factor: 10.154

4.  Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.

Authors:  C S Yu; F C Lin; K C Li; T Z Jiang; C Z Zhu; W Qin; H Sun; P Chan
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

5.  Immune agents for the treatment of Devic's neuromyelitis optica.

Authors:  R Bergamaschi
Journal:  Neurol Sci       Date:  2007-10       Impact factor: 3.307

6.  Early initiation of steroid pulse therapy for neuromyelitis optica in an emergency room setting.

Authors:  Saya Yamada; Sayaka Oikawa; Teppei Komatsu; Toshiaki Hirai; Kenji Dohi; Takeki Ogawa
Journal:  Acute Med Surg       Date:  2015-08-27

7.  Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.

Authors:  G Orman; K Y Wang; Y Pekcevik; C B Thompson; M Mealy; M Levy; I Izbudak
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-16       Impact factor: 3.825

8.  Visual evoked potentials in early diagnosis of demyelinating diseases--a case report of Devic's disease.

Authors:  Ewa Langwińska-Wośko; Kamil Szulborski; Karina Broniek-Kowalik
Journal:  Med Sci Monit       Date:  2012-10

9.  Are nonintestinal inflammatory diseases and celiac disease linked?: Nonintestinal inflammatory and celiac disease.

Authors:  Roberto Bergamaschi
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

10.  Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.

Authors:  Shumei Bai; Shilian Liu; Xuxiao Guo; Zhaoyu Qin; Banqin Wang; Xiaohong Li; Yanjiang Qin; Yi-Hsin Liu
Journal:  Mol Vis       Date:  2009-08-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.